New gene therapy may reduce bleeding risk for haemophilia patients - The Statesman

AAV gene therapy works by using a packaging from the proteins found in the outer coat of the virus, to deliver a functional copy of a gene directly to patient tissues.

A team of researchers, led by those of Indian-origin, has in a breakthrough developed a single gene therapy injection that could dramatically reduce the bleeding risk faced by people with haemophilia… [+2415 chars]

full article...